Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Current state of biomarker development for clinical application in epithelial ovarian cancer.

Moore RG, MacLaughlan S, Bast RC Jr.

Gynecol Oncol. 2010 Feb;116(2):240-5. doi: 10.1016/j.ygyno.2009.09.041. Epub 2009 Oct 31. Review.

2.

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1583.

3.

Recent developments in ovarian cancer screening.

Menon U, Jacobs IJ.

Curr Opin Obstet Gynecol. 2000 Feb;12(1):39-42. Review.

PMID:
10752515
4.

Current clinical use of biomarkers for epithelial ovarian cancer.

Moore RG, Maclaughlan S.

Curr Opin Oncol. 2010 Sep;22(5):492-7. doi: 10.1097/CCO.0b013e32833c3351. Review.

PMID:
20613519
5.

Update on ovarian cancer screening.

Munkarah A, Chatterjee M, Tainsky MA.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):22-6. Review.

PMID:
17218847
6.

Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Nolen BM, Lokshin AE.

Mol Diagn Ther. 2013 Jun;17(3):139-46. doi: 10.1007/s40291-013-0027-6. Review.

7.

Status of tumor markers in ovarian cancer screening.

Bast RC Jr.

J Clin Oncol. 2003 May 15;21(10 Suppl):200s-205s. Review.

PMID:
12743135
8.

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, Apostolidou S, Singh N, Benjamin E, Burnell M, Davies S, Sharma A, Gunu R, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Seif MW, Jenkins H, Mould T, Woolas R, Murdoch JB, Dobbs S, Amso NN, Leeson S, Cruickshank D, Scott I, Fallowfield L, Widschwendter M, Reynolds K, McGuire A, Campbell S, Parmar M, Skates SJ, Jacobs I.

J Clin Oncol. 2015 Jun 20;33(18):2062-71. doi: 10.1200/JCO.2014.59.4945. Epub 2015 May 11.

9.
10.

Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.

Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, Golightly M, Zucker S, Chen WT.

Gynecol Oncol. 2014 Sep;134(3):581-90. doi: 10.1016/j.ygyno.2014.06.013. Epub 2014 Jun 24.

11.

Advances in the early detection of ovarian carcinoma.

Garner EI.

J Reprod Med. 2005 Jun;50(6):447-53. Review.

PMID:
16050569
12.

The role of CA 125 in screening for ovarian cancer.

Rosenthal AN, Jacobs IJ.

Int J Biol Markers. 1998 Oct-Dec;13(4):216-20. Review.

PMID:
10228904
13.

The potential and problems of screening for ovarian cancer.

Yokoyama Y, Higuchi T, Mizunuma H.

Eur J Gynaecol Oncol. 2005;26(3):241-3.

PMID:
15991520
14.

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

Nossov V, Amneus M, Su F, Lang J, Janco JM, Reddy ST, Farias-Eisner R.

Am J Obstet Gynecol. 2008 Sep;199(3):215-23. doi: 10.1016/j.ajog.2008.04.009. Epub 2008 May 12. Review.

PMID:
18468571
15.

Detection and monitoring of ovarian cancer.

Su Z, Graybill WS, Zhu Y.

Clin Chim Acta. 2013 Jan 16;415:341-5. doi: 10.1016/j.cca.2012.10.058. Epub 2012 Nov 16. Review.

PMID:
23165217
16.

A comprehensive look at the early detection of ovarian cancer.

O'Rourke J, Mahon SM.

Clin J Oncol Nurs. 2003 Jan-Feb;7(1):41-7. Review.

PMID:
12629933
17.

Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.

Bast RC Jr.

Trans Am Clin Climatol Assoc. 2004;115:233-47; discussion 247-8. Review.

18.

HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.

Richards A, Herbst U, Manalang J, Pather S, Saidi S, Tejada-Berges T, Tan K, Williams P, Carter J.

Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):493-7. doi: 10.1111/ajo.12363. Epub 2015 Jul 14.

PMID:
26172511
19.

Familial ovarian cancer screening.

Rosenthal A, Jacobs I.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):321-38. Epub 2005 Dec 20. Review.

PMID:
16364691
20.

Advances in the early detection of ovarian cancer: How to hear the whispers early.

Cesario S.

Nurs Womens Health. 2010 Jun;14(3):222-34. doi: 10.1111/j.1751-486X.2010.01543.x. No abstract available.

PMID:
20579298

Supplemental Content

Support Center